Wound Care

Arteriocyte Trial Approved For Military Burn Wound Treatment

Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan® System technology in the treatment of thermal burn wounds.
The FDA Investigational Device Exemption (IDE-15140) allows Arteriocyte and its clinical partners to initiate evaluation of autologous platelet gel (APG) (using the Magellan® Autologous Platelet Separator technology) as an adj

Smith & Nephew to Acquire Assets of Healthpoint Biotherapeutics

The acquired medical device firm specializes in products for acute, chronic and burn-related wound care.

Smith & Nephew, the global medical technology business, announced today that it has signed an agreement to acquire substantially all of the assets of Healthpoint Biotherapeutics for $782 million in cash. The transaction is subject to regulatory approval and is expected to close in December 2012.

No votes yet

United Health Products Trauma Gauze Receives 510K Approval

The FDA has given the go-ahead for the company’s Hemostyp hemostatic gauze.

United Health Products, Inc. which develops and markets products and technologies in the healthcare sector, today announced that its hemostatic gauze which is registered and branded in the USA under the trademark Hemostyp™ has received 510K approval from the FDA under the application and registration of its manufacturing agent. Hemostyp was originally introduced into the market in 2002 as a Class I exempt product for external wound care and dental applications.

No votes yet

Devon Medical Products Wound Therapy Product Lands FDA Approval

The extriCARE2400 Negative Pressure Wound Therapy pump pairs with the company's anatomically fitting bandage products.


Devon Medical Products, a global medical device designer, manufacturer, and distributor, announced it has received Food & Drug Administration (FDA) 510(k) clearance to market its extriCARE 2400 Negative Pressure Wound Therapy (NPWT) system.

No votes yet

MediPlus Receives U.S. FDA 510(k) Clearance for Silver Advanced Wound Care Products

ATLANTA, Sept. 27—MediPurpose®, a master distributor and manufacturer of medical products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its MediPlus™ foam wound care products that contain antibacterial silver.
MediPurpose also announced that its expanding MediPlus™ advanced wound care product portfolio now includes Foam Ag, Comfort Foam Ag and Super Foam Ag dressings.

No votes yet
Syndicate content